Epidarex’s company-building model continues to deliver with Dunad’s $1.3 billion strategic collaboration with Novartis
November 2, 2021
Epidarex-built start-up signs major global development partnership within 18 months of launch. Epidarex portfolio company will receive $24 million in an upfront payment and equity